Na tej stronie
01COO cena
02Zrzut ekranu
03Wykres
04Podziały akcji
05O nas
06Wyniki
07Wycena i wskaźniki
13Dywidendy
14Zyski
15Pełne podstawowe wskaźniki
16Sprawozdania
17Właściciele instytucjonalni (13F)
19Insiderzy spółki
20Posiadanie ETF-ów
21Konsensus
22Równi
23Wiadomości
25Sygnały transakcyjne
26Moje wskaźniki
COO The Cooper Companies, Inc. - Common Stock
NASDAQ · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Wrz 9, 2026
$56,91
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$51,0152tyg. minimum
$89,8352tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$10.82B
P/E (TTM)
19.5
EPS (TTM)
$2.92
Przychody (TTM)
$4.24B
Twoje odznaki
Zakres 52 tyg.
$51–$90
Ocena Analityków
HOLD
Cena Docelowa
$66
P/E
19.5
ROE
6.8%
Marża Zysku Netto
13.5%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
COO Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$56.91
Kapitalizacja Rynkowa (MRQ)
$10.82B
P/E (TTM)
19.5
EPS (TTM)
$2.92
Przychody (TTM)
$4.24B
Stopa dywidendy
0.00%
ROE (TTM)
6.8%
D/E Dług/Kapitał (MRQ)
0.3
Zakres 52 tyg.
$51–$90
COO Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 20 lutego 2024 | 4-for-1 | Naprzód |
| 25 listopada 2002 | 2-for-1 | Naprzód |
| 22 września 1995 | 1-for-3 | Odwrotny |
O The Cooper Companies, Inc. - Common Stock Przegląd firmy z Wikipedii
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's healthcare market.
History
Parker Montgomery, a lawyer, bought Martin H. Smith Co. in 1958. The company was renamed to Cooper, Tinsley Laboratories, Inc. in 1961. Its name was changed to Cooper Laboratories Inc. in 1967, and entered the contact lens business when it acquired British lens maker GlobalVision in 1972.
In 1980, Cooper Laboratories reorganized into three business groups: CooperVision, CooperCare and CooperBiomedical, with Cooper Medical Devices Corp. added as a fourth group one year later.
The company was renamed The Cooper Companies in 1987. Three years later, it was further restructured into three business units: CooperVision, CooperSurgical and CooperVision Pharmaceuticals (dissolved in 2003).
Currently, the firm operates as two business units: CooperVision and CooperSurgical. CooperVision serves contact lens wearers and eye care practitioners. Products include a range of daily, two-week and monthly disposable contact lenses, and other spherical, toric and multifocal lenses for astigmatism, nearsightedness and farsightedness, and presbyopia.
CooperSurgical is the medical device and fertility and genomics unit of the companies. It became a business unit in 1990 and its focus includes women's health and fertility. It is headquartered in Trumbull, Connecticut.
Acquisitions
Ocular Sciences Inc. was acquired by CooperVision in 2005.
CooperSurgical acquired AEGEA Medical, a medical manufacturing company in February 2021. A month later, in March, the company acquired Safe Obstetric Systems, and in December 2021, CooperSurgical acquired Generate Life Sciences for $1.6 billion.
In March 2022, CooperSurgical acquired Cook Medical's reproductive health business for $875 million. During that same year the company acquired EnsEyers, a supplier of orthokeratology and scleral contact lenses.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
sektorHealth Care
branżaHealth Care
pracownicy15 000
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$4.09B2016-10-31 → 2025-10-31
EPS$1.872016-10-31 → 2025-10-31
Wolny przepływ pieniężny$434M2016-10-31 → 2025-10-31
Marża netto13.5%2016-10-31 → 2025-10-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | COO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 19.5średnia z 5 lat ≈36.1 | ≈36.1 | 28.5 | Niedowartościowany | |
| P/S (TTM) | 2.6średnia z 5 lat ≈2.5 | ≈2.5 | 2.1 | Zawyżona wycena | |
| P/B (MRQ) | 1.3średnia z 5 lat ≈1.2 | ≈1.2 | 2.1 | Niedowartościowany | |
| EV / EBITDA | 12.8średnia z 5 lat ≈13.5 | ≈13.5 | 16.6 | Wartość godziwa | |
| Cena / FCF (TTM) | 16.0średnia z 5 lat ≈27.9 | ≈27.9 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 10.5średnia z 5 lat ≈13.0 | ≈13.0 | 17.6 | Wartość godziwa | |
| EV / Revenue (EV / Przychody) | 3.3średnia z 5 lat ≈3.1 | ≈3.1 | · | · | |
| EV / FCF | 31.2średnia z 5 lat ≈34.4 | ≈34.4 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 1.6średnia z 5 lat ≈3.8 | ≈3.8 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | COO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 65.9%średnia z 5 lat ≈65.9% | ≈65.9% | 58.2% | Najwyższa półka | |
| Marża Operacyjna (TTM) | 12.8%średnia z 5 lat ≈16.5% | ≈16.5% | 11.8% | Najwyższa półka | |
| Marża EBITDA (TTM) | 21.9%średnia z 5 lat ≈22.3% | ≈22.3% | 17.6% | Najwyższa półka | |
| Marża przed opodatkowaniem (TTM) | 10.9%średnia z 5 lat ≈14.3% | ≈14.3% | 10.1% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | 13.5%średnia z 5 lat ≈28.0% | ≈28.0% | 6.7% | Najwyższa półka | |
| ROA (TTM) | 4.6%średnia z 5 lat ≈9.7% | ≈9.7% | 3.5% | Zgodnie z | |
| ROE (TTM) | 6.8%średnia z 5 lat ≈14.8% | ≈14.8% | 6.5% | Poniżej średniej | |
| ROIC | 4.2%średnia z 5 lat ≈10.6% | ≈10.6% | 5.1% | Poniżej średniej |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | COO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.3średnia z 5 lat ≈0.3 | ≈0.3 | 0.5 | Niski dług | |
| Wskaźnik bieżący (MRQ) | 1.2średnia z 5 lat ≈1.8 | ≈1.8 | 1.7 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 0.8średnia z 5 lat ≈0.8 | ≈0.8 | 0.5 | Zgodnie z | |
| Dług długoterminowy / Kapitał własny (MRQ) | 0.2średnia z 5 lat ≈0.3 | ≈0.3 | 0.8 | Niski dług |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | COO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 5.1%średnia z 5 lat ≈11.1% | ≈11.1% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 7.3%średnia z 5 lat ≈10.4% | ≈10.4% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 11.0% | · | · | · | |
| EPS YoY | -4.6%średnia z 5 lat ≈207.5% | ≈207.5% | · | · | |
| Net Income YoY (Zysk Netto R/R) | -4.4%średnia z 5 lat ≈210.7% | ≈210.7% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | -1.2%średnia z 5 lat ≈-33.9% | ≈-33.9% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | -17.2% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | -0.95%średnia z 5 lat ≈-14.2% | ≈-14.2% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | 9.5% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | COO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.3średnia z 5 lat ≈0.3 | ≈0.3 | 0.6 | Słaby | |
| Inventory Turnover (Rotacja zapasów) | 1.7średnia z 5 lat ≈1.8 | ≈1.8 | 2.7 | Słaby | |
| Receivables Turnover (Rotacja należności) | 5.3średnia z 5 lat ≈5.9 | ≈5.9 | 7.7 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$272.8K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy0.00%
Wskaźnik Wypłaty Dywidendy0.00%
Zannualizowane wypłaty≈$0.01
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Lip 26, 2023 | $0,01 | USD | ≈0.02% |
| Sty 20, 2023 | $0,01 | USD | ≈0.02% |
| Lip 26, 2022 | $0,01 | USD | ≈0.02% |
| Sty 20, 2022 | $0,01 | USD | ≈0.02% |
| Lip 26, 2021 | $0,01 | USD | ≈0.01% |
| Sty 21, 2021 | $0,01 | USD | ≈0.02% |
| Lip 22, 2020 | $0,01 | USD | ≈0.02% |
| Sty 22, 2020 | $0,01 | USD | ≈0.02% |
| Lip 22, 2019 | $0,01 | USD | ≈0.02% |
| Sty 18, 2019 | $0,01 | USD | ≈0.02% |
| Lip 20, 2018 | $0,01 | USD | ≈0.02% |
| Sty 22, 2018 | $0,01 | USD | ≈0.02% |
| Lip 19, 2017 | $0,01 | USD | ≈0.02% |
| Sty 19, 2017 | $0,01 | USD | ≈0.03% |
| Lip 20, 2016 | $0,01 | USD | ≈0.03% |
| Sty 20, 2016 | $0,01 | USD | ≈0.05% |
| Lip 22, 2015 | $0,01 | USD | ≈0.03% |
| Sty 21, 2015 | $0,01 | USD | ≈0.04% |
| Lip 22, 2014 | $0,01 | USD | ≈0.04% |
| Sty 22, 2014 | $0,01 | USD | ≈0.05% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
3.9%
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 września 2026 | Wrz 9, 2026 | $1.15 | $1.13 | 1.8% |
| 30 czerwca 2026 | Cze 4, 2026 | $1.21 | $1.11 | 9.3% |
| 31 marca 2026 | $1.10 | $1.04 | 5.7% | |
| 31 grudnia 2025 | $1.15 | $1.12 | 2.3% | |
| 30 września 2025 | $1.10 | $1.08 | 1.9% | |
| 30 czerwca 2025 | $0.96 | $0.94 | 2.5% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B | $2.43B | $2.65B | $2.53B | $2.14B | $1.97B | $1.80B | $1.72B | |
| Cost of Revenue | $1.41B | $1.30B | $1.24B | $1.17B | $967M | $896M | $897M | $900M | $773M | $794M | $727M | $626M | |
| Gross Profit | $2.68B | $2.60B | $2.36B | $2.14B | $1.96B | $1.53B | $1.76B | $1.63B | $1.37B | $1.17B | $1.07B | $1.09B | |
| R&D Expense | $172M | $155M | $137M | $110M | $93M | $93M | $87M | $85M | $69M | $65M | $70M | $66M | |
| SG&A Expense | $1.63B | $1.53B | $1.50B | $1.34B | $1.21B | $992M | $996M | $973M | $799M | $723M | $712M | $683M | |
| Operating Income | $683M | $706M | $533M | $508M | $506M | $312M | $547M | $403M | $429M | $324M | $237M | $306M | |
| Interest Expense | · | · | $105M | $57M | $23M | $37M | $68M | $83M | $33M | $26M | $18M | $8M | |
| Other Non-op | $-16M | $-9M | $-15M | $25M | $9M | $-8M | $-1M | $12M | $-2M | $-2M | $-3M | $-2M | |
| Pretax Income | $566M | $582M | $413M | $475M | $492M | $266M | $477M | $332M | $394M | $296M | $216M | $296M | |
| Income Tax | $192M | $190M | $119M | $90M | $-2.45B | $28M | $11M | $192M | $21M | $21M | $10M | $25M | |
| Net Income | $375M | $392M | $294M | $386M | $2.94B | $238M | $467M | $140M | $373M | $274M | $204M | $270M | |
| EPS (Basic) | $1.88 | $1.97 | $1.49 | $1.95 | $59.80 | $4.85 | $9.44 | $2.85 | $7.63 | $5.65 | $4.20 | $5.61 | |
| EPS (Diluted) | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 | $4.81 | $9.33 | $2.81 | $7.52 | $5.59 | $4.14 | $5.51 | |
| Shares (Basic) | 199,100,000 | 198,900,000 | 197,900,000 | 197,400,000 | 49,200,000 | 49,100,000 | 49,400,000 | 49,100,000 | 48,900,000 | 48,500,000 | 48,500,000 | 48,061,000 | |
| Shares (Diluted) | 200,000,000 | 200,400,000 | 199,300,000 | 198,800,000 | 49,800,000 | 49,600,000 | 50,000,000 | 49,700,000 | 49,600,000 | 49,000,000 | 49,200,000 | 49,000,000 | |
| EBITDA | $1.06B | $1.08B | $901M | $508M | $506M | $312M | $828M | $678M | $618M | $522M | $428M | $445M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $108M | $121M | $138M | $96M | $116M | $89M | $78M | $89M | $101M | $16M | $25M | |
| Receivables | $829M | $717M | $610M | $558M | $515M | $435M | $435M | $375M | $317M | $291M | $283M | $276M | |
| Inventory | $846M | $803M | $736M | $629M | $586M | $570M | $507M | $469M | $454M | $418M | $420M | $382M | |
| Prepaid Expense | $321M | $324M | $239M | $209M | $179M | $152M | $132M | $170M | $94M | $78M | $81M | $68M | |
| Current Assets | $2.11B | $1.95B | $1.70B | $1.53B | $1.47B | $1.27B | $1.16B | $1.09B | $953M | $937M | $841M | $792M | |
| PP&E (Net) | $2.08B | $1.86B | $1.63B | $1.41B | $1.35B | $1.28B | $1.13B | $976M | $910M | $878M | $967M | $937M | |
| PP&E (Gross) | $3.91B | $3.56B | $3.18B | $2.80B | $2.66B | $2.47B | $2.19B | $1.93B | $1.76B | $1.60B | $1.65B | $1.53B | |
| Accum. Depreciation | $1.83B | $1.70B | $1.55B | $1.39B | $1.31B | $1.19B | $1.06B | $954M | $847M | $726M | $684M | $589M | |
| Goodwill | $3.85B | $3.84B | $3.62B | $3.61B | $2.57B | $2.45B | $2.43B | $2.39B | $2.35B | $2.16B | $2.20B | $2.22B | |
| Intangibles | $1.59B | $1.79B | $1.71B | $1.89B | $1.27B | $1.29B | $1.41B | $1.52B | $505M | $441M | $411M | $454M | |
| Other Non-current Assets | $689M | $661M | $637M | $588M | $401M | $105M | $67M | $74M | $76M | $52M | $39M | $39M | |
| Total Assets | $12.39B | $12.32B | $11.66B | $11.49B | $9.61B | $6.74B | $6.27B | $6.11B | $4.86B | $4.48B | $4.46B | $4.46B | |
| Accounts Payable | $300M | $260M | $262M | $249M | $161M | $176M | $150M | $146M | $142M | $107M | $117M | $116M | |
| Short-term Debt | $47M | $32M | $44M | $396M | $83M | $409M | $564M | $37M | $23M | $226M | $244M | $102M | |
| Current Liabilities | $1.11B | $1.02B | $969M | $1.28B | $732M | $1.00B | $1.11B | $536M | $396M | $543M | $569M | $442M | |
| Capital Leases | $240M | $231M | $216M | $206M | $232M | $237M | · | · | · | · | · | · | |
| Deferred Tax | $93M | $96M | $102M | $150M | $24M | $26M | $28M | $31M | $39M | $38M | $31M | $70M | |
| Other Non-current Liabilities | $283M | $312M | $239M | $225M | · | · | · | · | · | · | · | · | |
| Total Liabilities | $4.16B | $4.23B | $4.11B | $4.32B | $2.66B | $2.91B | $2.65B | $2.81B | $1.68B | $1.78B | $1.79B | $1.87B | |
| Long-term Debt | · | · | · | · | · | · | · | $1.99B | $1.15B | $1.32B | $1.11B | $1.28B | |
| Total Debt | $2.50B | $2.58B | $2.56B | $2.35B | $1.40B | $1.38B | $1.26B | $2.02B | $1.17B | $1.54B | $1.35B | $1.38B | |
| Common Stock | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Paid-in Capital | $1.98B | $1.92B | $1.82B | $1.77B | $1.72B | $1.65B | $1.61B | $1.57B | $1.53B | $1.49B | $1.43B | $1.39B | |
| Retained Earnings | $7.64B | $7.27B | $6.88B | $6.58B | $6.20B | $3.26B | $3.03B | $2.58B | $2.43B | $2.05B | $1.78B | $1.58B | |
| Treasury Stock | $995M | $706M | $710M | $714M | $640M | $617M | $571M | $415M | $415M | $360M | $360M | $295M | |
| AOCI | $-406M | $-422M | $-454M | $-467M | $-341M | $-472M | $-447M | $-431M | $-375M | $-490M | $-192M | $-106M | |
| Stockholders' Equity | $8.24B | $8.08B | $7.55B | $7.17B | $6.94B | $3.82B | $3.63B | $3.31B | $3.18B | $2.70B | $2.67B | $2.57B | |
| Liabilities + Equity | $12.39B | $12.32B | $11.66B | $11.49B | $9.61B | $6.74B | $6.27B | $6.11B | $4.86B | $4.48B | $4.46B | $4.46B | |
| Shares Outstanding | 195,900,000 | 199,600,000 | 198,100,000 | 49,300,000 | 49,300,000 | 49,100,000 | · | · | 48,800,000 | 48,800,000 | 48,300,000 | 48,100,000 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $377M | $375M | $368M | $346M | $309M | · | $281M | $275M | $188M | $198M | $191M | $138M | |
| Stock-based Comp | $70M | $75M | $62M | $54M | $44M | $38M | $35M | $43M | $37M | $30M | $33M | $37M | |
| Deferred Tax | $135M | $119M | $45M | $54M | $-2.50B | $-900.0K | $-16M | $3M | $-7M | $-11M | $6M | $-16M | |
| Amort. of Intangibles | $199M | $201M | $186M | $180M | $146M | $137M | $146M | $147M | $68M | $61M | $52M | $36M | |
| Other Non-cash | $-162M | $-252M | $-161M | · | · | · | $-54M | $208M | $2M | $18M | $-42M | $26M | |
| Operating Cash Flow | $796M | $709M | $608M | $692M | $739M | $487M | $713M | $669M | $594M | $510M | $391M | $455M | |
| CapEx | $362M | $421M | $392M | $242M | $214M | $310M | $292M | $194M | $127M | $153M | $243M | $238M | |
| Investing Cash Flow | $-373M | $-765M | $-449M | $-1.83B | $-450M | $-364M | $-351M | $-1.52B | $-381M | $-419M | $-288M | $-1.35B | |
| Debt Issued | $3.11B | $3.52B | $2.12B | $1.51B | $1.43B | $3.20B | $1.14B | $2.75B | $1.41B | $1.58B | $1.20B | $2.56B | |
| Net Debt Issued | $-94M | $17M | $170M | $950M | $12M | $-30M | $-725M | $836M | $49M | $117M | $-171M | $895M | |
| Stock Repurchased | $290M | $0 | $0 | $78M | $25M | $48M | $156M | $0 | $55M | $0 | $67M | $76M | |
| Net Stock Activity | $-290M | $0 | $0 | $-78M | $-25M | $-48M | $-156M | $0 | $-55M | $0 | $-67M | $-76M | |
| Dividends Paid | $0 | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Financing Cash Flow | $-426M | $39M | $-174M | $1.19B | $-311M | $-96M | $-351M | $844M | $-228M | $-1M | $-107M | $842M | |
| Net Change in Cash | $3M | $-13M | $-18M | $42M | $-20M | $27M | $9M | $-9M | $-12M | $84M | $-9M | $-52M | |
| Taxes Paid | · | · | · | · | · | · | · | $19M | $16M | $29M | $12M | $16M | |
| Free Cash Flow | $434M | $288M | $215M | $450M | $524M | $176M | $421M | $475M | $466M | $357M | $148M | $217M | |
| Levered FCF | · | · | $140M | $404M | $386M | · | · | $440M | $435M | $333M | $131M | $209M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.5% | 66.6% | 65.6% | 64.7% | 66.9% | 63.1% | 66.2% | 64.5% | 63.8% | 59.6% | 59.6% | 63.5% | |
| Operating Margin | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% | 12.8% | 20.6% | 15.9% | 20.1% | 16.5% | 13.2% | 17.8% | |
| Net Margin | 9.2% | 10.1% | 8.2% | 11.7% | 100.8% | 9.8% | 17.6% | 5.5% | 17.4% | 13.9% | 11.3% | 15.7% | |
| Pretax Margin | 13.8% | 14.9% | 11.5% | 14.4% | 16.8% | · | · | 13.1% | 18.4% | 15.0% | 12.0% | 17.3% | |
| EBITDA Margin | 25.9% | 27.8% | 25.1% | 15.3% | 17.3% | 12.8% | 31.2% | 26.8% | 28.9% | 26.6% | 23.8% | 25.9% | |
| ROA | 3.0% | 3.3% | 2.5% | 3.7% | 36.0% | 3.7% | 7.5% | 2.5% | 8.0% | 6.1% | 4.6% | 7.1% | |
| ROE | 4.6% | 5.0% | 4.0% | 5.5% | 54.7% | 6.4% | 13.0% | 4.3% | 12.7% | 10.2% | 7.8% | 10.8% | |
| ROIC | 4.2% | 4.5% | 3.8% | 4.3% | 36.3% | · | · | 3.2% | 9.3% | 7.1% | 5.6% | 7.1% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.9 | 1.8 | 1.2 | 2.0 | 1.3 | 1.0 | 2.0 | 2.4 | 1.7 | 1.5 | 1.8 | |
| Quick Ratio | 0.8 | 0.8 | 0.8 | 0.5 | 0.8 | 0.5 | 0.5 | 0.8 | 1.0 | 0.7 | 0.5 | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.6 | 0.4 | 0.6 | 0.5 | 0.5 | |
| LT Debt / Equity | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.6 | 0.4 | 0.4 | 0.4 | 0.5 | |
| Interest Coverage | · | · | 5.1 | 8.9 | 21.9 | 8.5 | 8.0 | 4.9 | 12.8 | 12.4 | 13.1 | 38.5 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.4 | 0.5 | |
| Inventory Turnover | 1.7 | 1.7 | 1.8 | 1.9 | 1.7 | 1.7 | 1.8 | 2.0 | 1.8 | 1.9 | 1.8 | 1.7 | |
| Receivables Turnover | 5.3 | 5.9 | 6.2 | 6.2 | 6.1 | 5.6 | 6.6 | 7.3 | 7.0 | 6.8 | 6.4 | 6.8 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $42.06 | $40.50 | $152.54 | $145.53 | $140.81 | · | · | · | $65.08 | $55.34 | $55.26 | $53.38 | |
| Revenue / Share | $20.46 | $19.44 | $72.15 | $66.57 | $58.68 | $49.01 | $53.07 | $50.96 | $43.12 | $40.14 | $36.54 | $35.09 | |
| Cash Flow / Share | $3.98 | $3.54 | $12.20 | $13.93 | $14.83 | $9.81 | $14.26 | $13.46 | $11.97 | $10.40 | $7.95 | $9.29 | |
| Cash / Share | $0.56 | $0.54 | $2.44 | $2.80 | $1.95 | · | · | · | $1.82 | $2.07 | $0.34 | $0.52 | |
| Dividend / Share | · | · | $0.01 | $0.01 | · | · | · | · | · | · | · | · | |
| Dividend Paid / Share | · | · | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | |
| EPS (TTM) | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 | $4.81 | $9.33 | $2.81 | $7.52 | $5.59 | $4.14 | $5.51 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 5.1% | 8.4% | 8.6% | 13.2% | 20.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.3% | 10.1% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -4.6% | 32.4% | -23.7% | -96.7% | 1129.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -1.2% | -67.9% | -32.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -4.4% | 33.3% | -23.7% | -86.9% | 1135.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -0.95% | -48.9% | 7.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B | $2.43B | $2.65B | $2.53B | $2.14B | $1.97B | $1.80B | $1.72B | |
| Net Income TTM | $375M | $392M | $294M | $386M | $2.94B | $238M | $467M | $140M | $373M | $274M | $204M | $270M | |
| Market Cap | $13.70B | $20.89B | $3.86B | $3.37B | $5.14B | · | · | · | $2.93B | $2.15B | $1.84B | $1.97B | |
| Enterprise Value | $16.09B | $23.37B | $6.30B | $5.58B | $6.44B | · | · | · | $4.02B | $3.59B | $3.18B | $3.33B | |
| P/E | 37.4 | 53.4 | 52.7 | 35.2 | 1.8 | 16.6 | 7.8 | 23.0 | 8.0 | 7.9 | 9.2 | 7.4 | |
| P/S | 3.3 | 5.4 | 1.1 | 1.0 | 1.8 | · | · | · | 1.4 | 1.1 | 1.0 | 1.1 | |
| P/B | 1.7 | 2.6 | 0.5 | 0.5 | 0.7 | · | · | · | 0.9 | 0.8 | 0.7 | 0.8 | |
| P / Tangible Book | 4.9 | 8.5 | 1.7 | 2.0 | 1.7 | · | · | · | · | · | · | · | |
| P / Cash Flow | 17.2 | 29.5 | 6.4 | 4.9 | 7.0 | · | · | · | 4.9 | 4.2 | 4.7 | 4.3 | |
| P / FCF | 31.6 | 72.5 | 17.9 | 7.5 | 9.8 | · | · | · | 6.3 | 6.0 | 12.4 | 9.1 | |
| EV / EBITDA | 15.2 | 21.6 | 7.0 | 11.0 | 12.7 | · | · | · | 6.5 | 6.9 | 7.4 | 7.5 | |
| EV / FCF | 37.1 | 81.1 | 29.3 | 12.4 | 12.3 | · | · | · | 8.6 | 10.1 | 21.5 | 15.4 | |
| EV / Revenue | 3.9 | 6.0 | 1.8 | 1.7 | 2.2 | · | · | · | 1.9 | 1.8 | 1.8 | 1.9 | |
| Dividend Yield | 0.00% | 0.00% | 0.08% | 0.09% | 0.06% | · | · | · | 0.10% | 0.14% | 0.16% | 0.15% | |
| Earnings Yield | 2.7% | 1.9% | 1.9% | 2.8% | 56.8% | 6.0% | 12.8% | 4.3% | 12.5% | 12.7% | 10.9% | 13.5% | |
| Payout Ratio | 0.00% | 0.00% | 1.0% | 0.78% | 0.10% | 1.3% | 0.64% | 2.1% | 0.78% | 1.1% | 1.4% | 1.1% | |
| Annual Payout | $0 | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M |
Rachunek zysków i strat
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.07B | $1.08B | $1.02B | $1.07B | $1.06B | $1.00B | $965M | $1.02B | $1.00B | $943M | $932M | $927M | $930M | $877M | $858M | $848M | |
| Cost of Revenue | $354M | $346M | $329M | $414M | $368M | $323M | $304M | $341M | $340M | $311M | $308M | $321M | $320M | $294M | $300M | $311M | |
| Gross Profit | $712M | $735M | $695M | $651M | $692M | $679M | $660M | $678M | $663M | $631M | $624M | $606M | $610M | $583M | $558M | $537M | |
| R&D Expense | $42M | $42M | $44M | $41M | $45M | $46M | $41M | $38M | $39M | $39M | $40M | $37M | $36M | $33M | $32M | $29M | |
| SG&A Expense | $401M | $676M | $390M | $419M | $422M | $399M | $388M | $391M | $381M | $380M | $381M | $388M | $375M | $408M | $331M | $358M | |
| Operating Income | $222M | $-31M | $213M | $140M | $176M | $185M | $182M | $198M | $192M | $162M | $153M | $136M | $152M | $96M | $150M | $104M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $29M | $30M | · | $27M | $26M | $26M | · | |
| Other Non-op | $1M | $4M | $2M | $800.0K | $2M | $-16M | $-3M | $-3M | $-300.0K | $-3M | $-3M | $-3M | $-6M | $-5M | $-1M | $-8M | |
| Pretax Income | $202M | $-48M | $192M | $117M | $152M | $144M | $153M | $169M | $164M | $130M | $120M | $106M | $119M | $66M | $122M | $72M | |
| Income Tax | $-231M | $30M | $61M | $32M | $54M | $57M | $49M | $51M | $59M | $41M | $39M | $22M | $34M | $26M | $38M | $7M | |
| Net Income | $433M | $-78M | $131M | $85M | $98M | $88M | $104M | $118M | $105M | $89M | $81M | $84M | $85M | $40M | $85M | $66M | |
| EPS (Basic) | $2.24 | $-0.40 | $0.67 | $0.43 | $0.49 | $0.44 | $0.52 | $0.58 | $0.53 | $0.45 | $0.41 | $0.43 | $0.43 | $0.20 | $0.43 | $-4.54 | |
| EPS (Diluted) | $2.24 | $-0.40 | $0.66 | $0.42 | $0.49 | $0.44 | $0.52 | $0.59 | $0.52 | $0.44 | $0.41 | $0.42 | $0.43 | $0.20 | $0.43 | $-4.50 | |
| Shares (Basic) | 193,000,000 | 195,000,000 | 195,800,000 | · | 199,300,000 | 199,900,000 | 199,700,000 | · | 199,100,000 | 198,900,000 | 198,400,000 | · | 198,100,000 | 197,900,000 | 197,500,000 | · | |
| Shares (Diluted) | 193,400,000 | 195,000,000 | 196,700,000 | · | 200,000,000 | 200,700,000 | 201,200,000 | · | 200,600,000 | 200,500,000 | 199,900,000 | · | 199,600,000 | 199,200,000 | 198,700,000 | · | |
| EBITDA | $222M | $-31M | $308M | · | $176M | $185M | $273M | · | $192M | $162M | $250M | · | $152M | $96M | $239M | · |
Bilans
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $155M | $139M | $125M | $111M | $125M | $116M | $101M | $108M | $110M | $112M | $135M | $121M | $117M | $112M | $118M | $138M | |
| Receivables | $789M | $809M | $807M | $829M | $792M | $781M | $716M | $717M | $739M | $689M | $651M | · | $630M | $565M | $582M | · | |
| Inventory | $912M | $896M | $876M | $846M | $881M | $880M | $843M | $803M | $779M | $775M | $748M | · | $724M | $699M | $659M | · | |
| Prepaid Expense | $426M | $455M | $325M | $321M | $340M | $348M | $327M | $324M | $299M | $282M | $260M | · | $240M | $224M | $218M | · | |
| Current Assets | $2.28B | $2.30B | $2.13B | $2.11B | $2.14B | $2.13B | $1.99B | $1.95B | $1.93B | $1.86B | $1.79B | · | $1.71B | $1.60B | $1.58B | · | |
| PP&E (Net) | · | · | · | $2.08B | · | · | · | $1.86B | $1.75B | $1.71B | $1.68B | · | $1.53B | $1.49B | $1.46B | · | |
| PP&E (Gross) | · | · | · | $3.91B | · | · | · | $3.56B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | · | $1.83B | · | · | · | $1.70B | · | · | · | · | · | · | · | · | |
| Goodwill | $3.88B | $3.89B | $3.91B | $3.85B | $3.86B | $3.86B | $3.79B | $3.84B | $3.78B | $3.76B | $3.77B | · | $3.68B | $3.66B | $3.67B | · | |
| Intangibles | $1.45B | $1.49B | $1.54B | $1.59B | $1.64B | $1.69B | $1.74B | $1.79B | $1.79B | $1.80B | $1.85B | · | $1.77B | $1.81B | $1.86B | · | |
| Other Non-current Assets | $657M | $673M | $688M | $689M | $653M | $659M | $664M | $661M | $621M | $637M | $617M | · | $628M | $585M | $569M | · | |
| Total Assets | $12.67B | $12.48B | $12.42B | $12.39B | $12.38B | $12.41B | $12.22B | $12.32B | $12.11B | $12.05B | $12.03B | $11.66B | $11.70B | $11.54B | $11.56B | $11.49B | |
| Accounts Payable | $251M | $233M | $226M | $300M | $256M | $244M | $202M | $260M | $222M | $231M | $202M | · | $227M | $242M | $224M | · | |
| Short-term Debt | $628M | $598M | $620M | $47M | $46M | $59M | $48M | $32M | $40M | $41M | $45M | · | $63M | $58M | $52M | · | |
| Current Liabilities | $1.87B | $1.80B | $1.60B | $1.11B | $1.01B | $1.01B | $1000M | $1.02B | $970M | $952M | $965M | · | $994M | $949M | $916M | · | |
| Capital Leases | · | · | · | $240M | · | · | · | $231M | · | · | · | · | · | · | · | · | |
| Deferred Tax | $94M | $96M | $96M | $93M | $102M | $99M | $95M | $96M | $95M | $94M | $90M | · | $138M | $139M | $144M | · | |
| Other Non-current Liabilities | $257M | $266M | $277M | $283M | $263M | $274M | $261M | $312M | $277M | $278M | $281M | · | · | · | · | · | |
| Total Liabilities | $4.34B | $4.24B | $4.06B | $4.16B | $4.02B | $4.13B | $4.09B | $4.23B | $4.18B | $4.24B | $4.34B | · | $4.17B | $4.16B | $4.23B | · | |
| Total Debt | $2.54B | $2.46B | $2.50B | · | $2.48B | $2.58B | $2.54B | · | $2.63B | $2.71B | $2.77B | · | $2.57B | $2.62B | $2.68B | · | |
| Common Stock | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | · | $5M | $5M | $5M | · | |
| Paid-in Capital | $2.00B | $1.98B | $1.99B | $1.98B | $1.96B | $1.94B | $1.93B | $1.92B | $1.88B | $1.87B | $1.85B | · | $1.82B | $1.80B | $1.78B | · | |
| Retained Earnings | $8.13B | $7.70B | $7.77B | $7.64B | $7.56B | $7.46B | $7.37B | $7.27B | $7.15B | $7.05B | $6.96B | · | $6.79B | $6.71B | $6.67B | · | |
| Treasury Stock | $1.44B | $1.10B | $1.09B | $995M | $796M | $745M | $705M | $706M | $707M | $708M | $709M | · | $711M | $712M | $713M | · | |
| AOCI | $-383M | $-363M | $-334M | $-406M | $-392M | $-392M | $-490M | $-422M | $-425M | $-423M | $-422M | · | $-375M | $-424M | $-404M | · | |
| Stockholders' Equity | $8.33B | $8.24B | $8.36B | $8.24B | $8.35B | $8.29B | $8.13B | $8.08B | $7.92B | $7.80B | $7.70B | · | $7.53B | $7.38B | $7.34B | · | |
| Liabilities + Equity | $12.67B | $12.48B | $12.42B | $12.39B | $12.38B | $12.41B | $12.22B | $12.32B | $12.11B | $12.05B | $12.03B | · | $11.70B | $11.54B | $11.56B | · | |
| Shares Outstanding | 190,100,000 | 194,900,000 | 195,100,000 | 195,900,000 | 198,800,000 | 199,500,000 | 199,900,000 | 199,600,000 | 199,100,000 | 199,100,000 | 198,700,000 | · | 49,500,000 | 49,500,000 | 49,400,000 | · |
Przepływy pieniężne
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $95M | $95M | $96M | $98M | $95M | $93M | $91M | $91M | $89M | $98M | $97M | $93M | $94M | $91M | $90M | $89M | |
| Deferred Tax | $-275M | $44M | $44M | $13M | $44M | $44M | $35M | $22M | $36M | $32M | $29M | · | · | · | · | $-1M | |
| Amort. of Intangibles | $47M | $48M | $48M | $50M | $50M | $50M | $50M | $50M | $50M | $50M | $50M | $46M | $47M | $46M | $46M | $46M | |
| Other Non-cash | · | · | $-45M | · | · | · | $-115M | · | · | · | $-165M | · | · | · | $-36M | · | |
| Operating Cash Flow | $342M | $183M | $261M | $248M | $261M | $96M | $191M | $268M | $208M | $111M | $123M | $174M | $142M | $124M | $167M | $131M | |
| CapEx | $69M | $86M | $102M | $98M | $97M | $78M | $89M | $140M | $89M | $74M | $118M | $145M | $91M | $74M | $83M | $95M | |
| Investing Cash Flow | $-70M | $-90M | $-103M | $-99M | $-98M | $-79M | $-97M | $-242M | $-124M | $-75M | $-324M | $-161M | $-93M | $-82M | $-113M | $-100M | |
| Debt Issued | $1.11B | $858M | $875M | $936M | $756M | $749M | $670M | $716M | $1.40B | $608M | $795M | $472M | $453M | $497M | $702M | $12M | |
| Net Debt Issued | · | · | $-29M | · | · | · | $-59M | · | · | · | $202M | · | · | · | $276M | · | |
| Stock Repurchased | $339M | $16M | $92M | $197M | $53M | $41M | $0 | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Stock Activity | · | · | $-92M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Dividends Paid | · | · | · | · | · | · | · | $0 | $0 | · | · | $2M | $0 | · | · | $2M | |
| Financing Cash Flow | $-253M | $-76M | $-148M | $-164M | $-156M | $-9M | $-97M | $-28M | $-88M | $-57M | $212M | $-6M | $-43M | $-47M | $-78M | $-134M | |
| Net Change in Cash | $16M | $14M | $14M | $-14M | $9M | $15M | $-7M | $-2M | $-3M | $-23M | $14M | $3M | $5M | $-6M | $-20M | $-108M | |
| Free Cash Flow | · | · | $159M | · | · | · | $101M | · | · | · | $5M | · | · | · | $84M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $-16M | · | · | · | $66M | · |
Rentowność
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.8% | 68.0% | 67.9% | · | 65.3% | 67.8% | 68.4% | · | 66.1% | 67.0% | 67.0% | · | 65.6% | 66.4% | 65.1% | · | |
| Operating Margin | 20.8% | -2.9% | 20.8% | · | 16.6% | 18.4% | 18.9% | · | 19.2% | 17.2% | 16.4% | · | 16.3% | 11.0% | 17.4% | · | |
| Net Margin | 40.6% | -7.2% | 12.8% | · | 9.3% | 8.8% | 10.8% | · | 10.4% | 9.4% | 8.7% | · | 9.2% | 4.5% | 9.8% | · | |
| Pretax Margin | 18.9% | -4.5% | 18.8% | · | 14.3% | 14.4% | 15.9% | · | 16.3% | 13.8% | 12.9% | · | 12.8% | 7.5% | 14.2% | · | |
| EBITDA Margin | 20.8% | -2.9% | 30.1% | · | 16.6% | 18.4% | 28.3% | · | 19.2% | 17.2% | 26.8% | · | 16.3% | 11.0% | 27.9% | · | |
| ROA | 3.5% | -0.63% | 1.1% | · | 0.80% | 0.72% | 0.86% | · | 0.88% | 0.75% | 0.69% | · | 0.73% | 0.34% | 0.73% | · | |
| ROE | 5.2% | -0.94% | 1.6% | · | 1.2% | 1.1% | 1.3% | · | 1.4% | 1.2% | 1.1% | · | 1.2% | 0.55% | 1.2% | · | |
| ROIC | 4.4% | -0.47% | 1.3% | · | 1.1% | 1.0% | 1.2% | · | 1.2% | 1.1% | 0.99% | · | 1.1% | 0.58% | 1.0% | · |
Płynność i wypłacalność
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.3 | 1.3 | · | 2.1 | 2.1 | 2.0 | · | 2.0 | 2.0 | 1.9 | · | 1.7 | 1.7 | 1.7 | · | |
| Quick Ratio | 0.5 | 0.5 | 0.6 | · | 0.9 | 0.9 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.7 | 0.8 | · | |
| Debt / Equity | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.4 | · | |
| LT Debt / Equity | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | 0.3 | 0.4 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 5.6 | 5.1 | · | 5.7 | 3.7 | 5.7 | · |
Efektywność
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | |
| Inventory Turnover | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | |
| Receivables Turnover | 1.3 | 1.4 | 1.3 | · | 1.4 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · |
Na akcję
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $43.81 | $42.27 | $42.87 | · | $42.02 | $41.54 | $40.66 | · | $39.80 | $39.19 | $38.73 | · | $152.09 | $149.05 | $148.49 | · | |
| Revenue / Share | $5.51 | $5.55 | $5.21 | · | $5.30 | $4.99 | $4.79 | · | $5.00 | $4.70 | $4.66 | · | $18.64 | $17.62 | $17.27 | · | |
| Cash Flow / Share | · | · | $1.33 | · | · | · | $0.95 | · | · | · | $0.61 | · | · | · | $3.35 | · | |
| Cash / Share | $0.81 | $0.71 | $0.64 | · | $0.63 | $0.58 | $0.50 | · | $0.55 | $0.56 | $0.68 | · | $2.37 | $2.26 | $2.39 | · | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | · | · | · | $0.01 | · | $0.01 | · | |
| EPS (TTM) | $2.92 | $1.17 | $2.01 | · | $2.04 | $2.07 | $2.07 | · | $1.79 | $1.70 | $1.46 | · | $-3.44 | $-1.89 | $0.46 | · |
Wycena (TTM)
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.24B | $4.23B | $4.15B | · | $4.05B | $3.99B | $3.93B | · | $3.80B | $3.73B | $3.67B | · | $3.51B | $3.43B | $3.38B | · | |
| Net Income TTM | $570M | $236M | $401M | · | $408M | $414M | $415M | · | $359M | $340M | $291M | · | $275M | $288M | $375M | · | |
| Market Cap | $13.75B | $12.26B | $15.81B | · | $14.05B | $16.29B | $19.30B | · | $18.58B | $17.73B | $18.53B | · | $4.84B | $4.72B | $4.31B | · | |
| Enterprise Value | $16.14B | $14.58B | $18.18B | · | $16.40B | $18.76B | $21.74B | · | $21.10B | $20.33B | $21.16B | · | $7.30B | $7.23B | $6.87B | · | |
| P/E | 24.8 | 53.8 | 40.3 | · | 34.7 | 39.5 | 46.6 | · | 52.1 | 52.4 | 63.9 | · | -28.4 | -50.5 | 189.6 | · | |
| P/S | 3.2 | 2.9 | 3.8 | · | 3.5 | 4.1 | 4.9 | · | 4.9 | 4.8 | 5.1 | · | 1.4 | 1.4 | 1.3 | · | |
| P/B | 1.7 | 1.5 | 1.9 | · | 1.7 | 2.0 | 2.4 | · | 2.3 | 2.3 | 2.4 | · | 0.6 | 0.6 | 0.6 | · | |
| P / Tangible Book | 4.6 | 4.3 | 5.4 | · | 4.9 | 6.0 | 7.4 | · | 7.9 | 7.9 | 8.9 | · | 2.3 | 2.5 | 2.4 | · | |
| P / Cash Flow | · | · | 60.6 | · | · | · | 101.3 | · | · | · | 151.0 | · | · | · | 25.9 | · | |
| EV / Revenue | 3.8 | 3.4 | 4.4 | · | 4.1 | 4.7 | 5.5 | · | 5.5 | 5.4 | 5.8 | · | 2.1 | 2.1 | 2.0 | · | |
| Earnings Yield | 4.0% | 1.9% | 2.5% | · | 2.9% | 2.5% | 2.1% | · | 1.9% | 1.9% | 1.6% | · | -3.5% | -2.0% | 0.53% | · |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Przychody | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B |
| Marża Brutto % | 65.5% | 66.6% | 65.6% | 64.7% | 66.9% |
| Marża Operacyjna % | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% |
| Zysk netto | $375M | $392M | $294M | $386M | $2.94B |
| Rozwodniony EPS | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 |
| Wskaźnik | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 |
| Wskaźnik bieżący | 1.9 | 1.9 | 1.8 | 1.2 | 2.0 |
| Wskaźnik Szybkości | 0.8 | 0.8 | 0.8 | 0.5 | 0.8 |
| Wskaźnik | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $434M | $288M | $215M | $450M | $524M |
Właściciele instytucjonalni (13F) 734 emitenci · $15.9B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
734
Wartość posiadanych akcji
$15.9B
Nowe pozycje
110
Zamknięte pozycje
98
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 110 (-5 vs poprzedni kw.) | 98 (+14 vs poprzedni kw.) | 259 (+25 vs poprzedni kw.) | 236 (-6 vs poprzedni kw.) | +2.5M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1 930 069 728 | 23 548 923 | 12,11% | Akcje |
| BlackRock, Inc. | $1 077 762 042 | 15 029 453 | 6,76% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $914 931 325 | 12 758 769 | 5,74% | Akcje |
| STATE STREET CORP | $637 691 430 | 8 892 643 | 4,00% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $621 703 470 | 8 669 690 | 3,90% | Akcje |
| BROWNING WEST LP | $515 984 142 | 7 195 428 | 3,24% | Akcje |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $389 405 563 | 5 430 282 | 2,44% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $382 865 202 | 5 359 812 | 2,40% | Akcje |
| FRANKLIN RESOURCES INC | $365 497 867 | 5 096 888 | 2,29% | Akcje |
| GENERATION INVESTMENT MANAGEMENT LLP | $356 303 541 | 4 968 673 | 2,24% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $287 152 440 | 4 004 357 | 1,80% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $285 686 067 | 4 022 614 | 1,79% | Akcje |
| Longview Partners (Guernsey) LTD | $282 537 902 | 3 940 007 | 1,77% | Akcje |
| UBS Group AG | $281 964 653 | 3 932 013 | 1,77% | Akcje |
| CITADEL ADVISORS LLC | $277 689 589 | 3 872 397 | 1,74% | Akcje |
| Invesco Ltd. | $264 254 073 | 3 685 038 | 1,66% | Akcje |
| JANA Partners Management, LP | $256 899 641 | 3 582 480 | 1,61% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $248 758 476 | 3 468 951 | 1,56% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $239 621 575 | 3 341 607 | 1,50% | Akcje |
| JANUS HENDERSON GROUP PLC | $219 298 853 | 3 067 125 | 1,38% | Akcje |
| LONDON CO OF VIRGINIA | $207 821 082 | 2 898 075 | 1,30% | Akcje |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $195 854 209 | 2 731 198 | 1,23% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $187 836 665 | 2 343 776 | 1,18% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $180 899 937 | 2 530 069 | 1,14% | Akcje |
| BARCLAYS PLC | $152 030 580 | 2 120 075 | 0,95% | Akcje |
| BANK OF AMERICA CORP /DE/ | $144 125 264 | 2 009 835 | 0,90% | Akcje |
| River Road Asset Management, LLC | $142 048 546 | 1 980 875 | 0,89% | Akcje |
| Sustainable Growth Advisers, LP | $139 698 824 | 1 948 108 | 0,88% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $132 231 017 | 1 843 969 | 0,83% | Akcje |
| MORGAN STANLEY | $129 451 390 | 1 805 205 | 0,81% | Akcje |
| NORTHERN TRUST CORP | $122 198 356 | 1 704 063 | 0,77% | Akcje |
| Gates Capital Management, Inc. | $121 088 717 | 1 688 589 | 0,76% | Akcje |
| Alecta Tjanstepension Omsesidigt | $112 082 730 | 1 563 000 | 0,70% | Akcje |
| MANNING & NAPIER ADVISORS LLC | $107 938 609 | 1 505 210 | 0,68% | Akcje |
| GOLDMAN SACHS GROUP INC | $107 170 245 | 1 494 495 | 0,67% | Akcje |
| Amundi | $101 548 173 | 1 416 095 | 0,64% | Akcje |
| Focus Partners Wealth | $101 143 265 | 1 410 461 | 0,63% | Akcje |
| Findlay Park Partners LLP | $92 075 640 | 1 284 000 | 0,58% | Akcje |
| WELLS FARGO & COMPANY/MN | $82 870 197 | 1 155 630 | 0,52% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $78 580 965 | 1 095 816 | 0,49% | Akcje |
| Holocene Advisors, LP | $77 495 348 | 1 080 677 | 0,49% | Akcje |
| Bank of New York Mellon Corp | $73 642 162 | 1 026 945 | 0,46% | Akcje |
| Balyasny Asset Management L.P. | $71 022 946 | 990 419 | 0,45% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $69 128 942 | 964 007 | 0,43% | Akcje |
| FMR LLC | $66 919 501 | 933 197 | 0,42% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $63 808 602 | 889 815 | 0,40% | Akcje |
| JPMORGAN CHASE & CO | $63 430 969 | 879 426 | 0,40% | Akcje |
| DEUTSCHE BANK AG\ | $61 203 267 | 853 483 | 0,38% | Akcje |
| Legal & General Group Plc | $60 521 302 | 843 973 | 0,38% | Akcje |
| TORONTO DOMINION BANK | $56 349 846 | 785 802 | 0,35% | Akcje |
Insiderzy spółki 51 insiderów · 25 dyrektorzy generalni · 21 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert D Auerbach | Special Advisor to the CEO | 1 lutego 2021 M | 2 759 | 0 | 0 | $0 |
| REMMELL PAUL L | Pres & CEO - CooperSurgical | 14 lipca 2017 M | 1 352 | 0 | 0 | $0 |
| Nicholas J Pichotta | Pres, CEO Cooper Medical, Inc. | 8 stycznia 2014 M | 10 697 | 0 | 0 | $0 |
| Brian G Andrews | EVP, CFO & Treasurer | 10 grudnia 2024 A | 8 537 | 0 | 0 | $0 |
| Gregory W Matz | SVP, CFO & CRO | 13 czerwca 2016 M | 15 123 | 0 | 0 | $0 |
| Steven M Neil | EVP & CFO | 16 stycznia 2008 P | 4 300 | 0 | 0 | $0 |
| John J Calcagno | CFO - CooperVision | 25 października 2007 A | 0 | 0 | 0 | $0 |
| Gerard H Warner III | President, CooperVision, Inc. | 8 stycznia 2026 M | 23 852 | 0 | 0 | $0 |
| Holly R Sheffield | President, CSI | 8 stycznia 2026 M | 43 261 | 1 | 0 | $99 322 |
| John Arthur Weber | President, CooperVision, Inc. | 8 stycznia 2014 M | 15 260 | 0 | 0 | $0 |
| Dennis Murphy | President Americas, CVI | 11 września 2009 M | 0 | 0 | 0 | $0 |
| Gregory A Fryling | Pres & COO - CVI | 24 października 2006 A | 3 790 | 0 | 0 | $0 |
| Agostino Ricupati | SVP & CAO | 1 kwietnia 2025 M | 8 020 | 0 | 0 | $0 |
| Nicholas Khadder | VP, General Counsel & Corp Sec | 8 stycznia 2025 M | 2 506 | 0 | 0 | $0 |
| Mark J Drury | VP, General Counsel & Sec. | 8 stycznia 2022 M | 2 197 | 0 | 0 | $0 |
| Randal Golden | VP, General Counsel & Sec. | 3 lutego 2020 M | 1 673 | 0 | 0 | $0 |
| Carol R Kaufman | EVP, Sec. & Chief Gov. Officer | 11 kwietnia 2018 G | 45 898 | 0 | 0 | $0 |
| Tina Maloney | VP, Corporate Controller | 8 stycznia 2017 M | 2 874 | 0 | 0 | $0 |
| Rodney Folden | VP & Corporate Controller | 8 stycznia 2014 M | 8 592 | 0 | 0 | $0 |
| Eugene J Midlock | VP Tax | 9 stycznia 2012 M | 2 137 | 0 | 0 | $0 |
| Jeffrey Alan Mclean | Exec VP, Comm. Strategies-CVI | 11 grudnia 2008 A | 0 | 0 | 0 | $0 |
| Christopher J Marmo | VP, R&D of CooperVision, Inc. | 24 października 2006 A | · | 0 | 0 | $0 |
| Norris B Battin | VP, Investor Relations | 24 października 2006 A | 4 000 | 0 | 0 | $0 |
| David Acosta | Treasurer | 8 kwietnia 2005 S | 10 000 | 0 | 0 | $0 |
| Stephen Whiteford | VP, Corporate Controller | 20 stycznia 2004 M | 15 052 | 0 | 0 | $0 |
| Lawrence E. Kurzius | Dyrektor | 16 września 2026 P | 31 099 | 3 | 0 | $1 253 500 |
| Walter M Rosebrough Jr | Dyrektor | 14 września 2026 P | 20 000 | 2 | 0 | $541 640 |
| Keel Paul A | Dyrektor | 11 września 2026 P | 4 701 | 1 | 0 | $249 999 |
| Barbara Carbone | Dyrektor | 1 kwietnia 2026 A | 3 050 | 0 | 0 | $0 |
| Maria Rivas | Dyrektor | 1 kwietnia 2026 A | 3 322 | 1 | 0 | $82 130 |
| Colleen Jay | Dyrektor | 1 kwietnia 2026 A | 39 907 | 0 | 0 | $0 |
| Robert S Weiss | Dyrektor | 1 kwietnia 2026 A | 292 599 | 0 | 0 | $0 |
| MADDEN TERESA S | Dyrektor | 1 kwietnia 2026 A | 15 679 | 0 | 0 | $0 |
| William A Kozy | Dyrektor | 1 kwietnia 2025 M | 31 149 | 0 | 0 | $0 |
| Gary S Petersmeyer | Dyrektor | 22 marca 2024 G | 1 523 | 0 | 0 | $0 |
| Jody S Lindell | Dyrektor | 6 stycznia 2023 M | 13 543 | 0 | 0 | $0 |
| Michael Kalkstein | Dyrektor | 1 kwietnia 2020 M | 0 | 0 | 0 | $0 |
| Allan E Rubenstein | Dyrektor | 1 kwietnia 2020 A | 3 091 | 0 | 0 | $0 |
| Thomas A Bender | Dyrektor | 1 kwietnia 2020 A | 12 952 | 0 | 0 | $0 |
| Stanley Zinberg MD | Dyrektor | 12 marca 2019 M | 10 528 | 0 | 0 | $0 |
| Steven Rosenberg | Dyrektor | 5 stycznia 2016 A | 12 359 | 0 | 0 | $0 |
| Donald Press | Dyrektor | 7 stycznia 2014 A | 43 970 | 0 | 0 | $0 |
| Moses Marx | Dyrektor | 1 grudnia 2009 A | 107 532 | 0 | 0 | $0 |
| FRUTH JOHN D | Dyrektor | 14 stycznia 2008 A | 6 500 | 0 | 0 | $0 |
| Edgar J Cummins | Dyrektor | 27 grudnia 2005 S | 1 764 | 0 | 0 | $0 |
| COOPER COMPANIES INC | Dyrektor | 1 listopada 2004 A | · | 0 | 0 | $0 |
| Cynthia L Lucchese | · | 1 kwietnia 2026 A | 12 767 | 1 | 0 | $149 963 |
| Daniel G Mcbride | · | 8 stycznia 2026 M | 69 352 | 0 | 0 | $0 |
| Albert G White III | · | 10 grudnia 2024 A | 245 072 | 1 | 0 | $808 000 |
| Andrew Sedgwick | · | 30 września 2009 M | 0 | 0 | 0 | $0 |
| James M Welch | · | 27 października 2005 A | 0 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 100 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 2,96% | 18 688 NS | 31 lipca 2026 | N-PORT |
| EQTY · Valued Advisers Trust | 2,01% | 396 156 NS | 31 lipca 2026 | N-PORT |
| CVSM · Elevation Series Trust | 1,88% | 24 508 NS | 31 lipca 2026 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 1,58% | 45 751 SH | 1 października 2026 | Dziennie |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,45% | 224 673 SH | 1 października 2026 | Dziennie |
| BSMQ · Invesco Exchange-Traded Self-Indexe… | 0,73% | 1 880 000 | 1 października 2026 | Dziennie |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0,56% | 115 163 SH | 1 października 2026 | Dziennie |
| FBCV · FIDELITY COVINGTON TRUST | 0,45% | 11 032 NS | 31 lipca 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,43% | 61 771 NS | 31 lipca 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,37% | 746 479 NS | 31 lipca 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,31% | 85 593 NS | 31 lipca 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,30% | 2 841 101 SH | 19 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,21% | 586 725 SH | 19 sierpnia 2026 | Dziennie |
| BSMU · Invesco Exchange-Traded Self-Indexe… | 0,21% | 545 000 | 1 października 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,20% | 92 713 NS | 31 lipca 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,18% | 3 081 517 SH | 1 października 2026 | Dziennie |
| SIZE · iShares Trust | 0,17% | 13 773 SH | 11 września 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,17% | 4 474 789 SH | 19 sierpnia 2026 | Dziennie |
| IYH · iShares Trust | 0,17% | 114 003 SH | 11 września 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 0,16% | 3 839 NS | 31 lipca 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,14% | 50 851 SH | 11 września 2026 | Dziennie |
| ISCG · iShares Trust | 0,14% | 25 105 SH | 11 września 2026 | Dziennie |
| IXJ · iShares Trust | 0,13% | 102 346 SH | 11 września 2026 | Dziennie |
| DFSV · Dimensional ETF Trust | 0,13% | 142 024 NS | 31 lipca 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 7 195 NS | 31 lipca 2026 | N-PORT |
| EVUS · iShares Trust | 0,11% | 7 759 SH | 11 września 2026 | Dziennie |
| IWS · iShares Trust | 0,10% | 290 845 SH | 11 września 2026 | Dziennie |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 13 930 SH | 1 października 2026 | Dziennie |
| BSMT · Invesco Exchange-Traded Self-Indexe… | 0,10% | 270 000 | 1 października 2026 | Dziennie |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,09% | 19 651 NS | 31 lipca 2026 | N-PORT |
| IWR · iShares Trust | 0,08% | 796 790 SH | 11 września 2026 | Dziennie |
| BAB · Invesco Exchange-Traded Fund Trust … | 0,07% | 592 000 | 1 października 2026 | Dziennie |
| BSMR · Invesco Exchange-Traded Self-Indexe… | 0,06% | 215 000 | 1 października 2026 | Dziennie |
| VFVA · VANGUARD WELLINGTON FUND | 0,06% | 7 148 SH | 19 sierpnia 2026 | Dziennie |
| XOEF · iShares Trust | 0,06% | 245 SH | 11 września 2026 | Dziennie |
| VLUE · iShares Trust | 0,06% | 105 585 SH | 11 września 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,05% | 3 837 NS | 31 lipca 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,05% | 44 755 SH | 19 sierpnia 2026 | Dziennie |
| DFUV · Dimensional ETF Trust | 0,05% | 103 993 NS | 31 lipca 2026 | N-PORT |
| BSMS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 155 000 | 1 października 2026 | Dziennie |
| CHRI · Global X Funds | 0,04% | 47 NS | 31 lipca 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,04% | 266 539 NS | 31 lipca 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 117 246 SH | 19 sierpnia 2026 | Dziennie |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 6 125 SH | 1 października 2026 | Dziennie |
| IVE · iShares Trust | 0,04% | 325 198 SH | 11 września 2026 | Dziennie |
| IUSV · iShares Trust | 0,03% | 172 535 SH | 11 września 2026 | Dziennie |
| EGLE · Global X Funds | 0,03% | 10 NS | 31 lipca 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,03% | 5 NS | 31 lipca 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,03% | 9 216 SH | 30 września 2026 | Dziennie |
| SUSL · iShares Trust | 0,03% | 6 864 SH | 11 września 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,03% | 63 415 NS | 31 lipca 2026 | N-PORT |
| DSI · iShares Trust | 0,03% | 29 689 SH | 11 września 2026 | Dziennie |
| DCOR · Dimensional ETF Trust | 0,03% | 13 489 NS | 31 lipca 2026 | N-PORT |
| IWD · iShares Trust | 0,03% | 434 725 SH | 11 września 2026 | Dziennie |
| TILT · FlexShares Trust | 0,03% | 8 374 NS | 31 lipca 2026 | N-PORT |
| XRMI · Global X Funds | 0,03% | 190 NS | 31 lipca 2026 | N-PORT |
| CRBN · iShares Trust | 0,03% | 5 717 SH | 11 września 2026 | Dziennie |
| XCLR · Global X Funds | 0,03% | 13 NS | 31 lipca 2026 | N-PORT |
| XYLG · Global X Funds | 0,03% | 225 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,03% | 43 268 NS | 31 lipca 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,02% | 42 256 SH | 1 października 2026 | Dziennie |
| DFSU · Dimensional ETF Trust | 0,02% | 7 349 NS | 31 lipca 2026 | N-PORT |
| XYLD · Global X Funds | 0,02% | 9 976 NS | 31 lipca 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,02% | 16 763 NS | 31 lipca 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,02% | 9 935 NS | 31 lipca 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0,02% | 456 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,02% | 61 254 NS | 31 lipca 2026 | N-PORT |
| XTR · Global X Funds | 0,02% | 14 NS | 31 lipca 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,02% | 736 NS | 31 lipca 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,02% | 5 069 056 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 6 191 667 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 31 957 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 16 452 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,02% | 43 944 SH | 19 sierpnia 2026 | Dziennie |
| QDPL · Pacer Funds Trust | 0,02% | 4 676 NS | 31 lipca 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,02% | 33 939 SH | 1 października 2026 | Dziennie |
| TOPC · iShares Trust | 0,02% | 115 SH | 11 września 2026 | Dziennie |
| XVV · iShares Trust | 0,02% | 2 209 SH | 11 września 2026 | Dziennie |
| HCMT · Direxion Shares ETF Trust | 0,02% | 1 360 NS | 31 lipca 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,02% | 1 151 SH | 29 września 2026 | Dziennie |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,02% | 33 649 SH | 1 października 2026 | Dziennie |
| SPXL · Direxion Shares ETF Trust | 0,02% | 15 254 NS | 31 lipca 2026 | N-PORT |
| IVV · iShares Trust | 0,02% | 2 459 565 SH | 11 września 2026 | Dziennie |
| IYY · iShares Trust | 0,02% | 8 448 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,02% | 55 887 SH | 11 września 2026 | Dziennie |
| IWB · iShares Trust | 0,02% | 134 163 SH | 11 września 2026 | Dziennie |
| VOXP · Advisors Series Trust | 0,02% | 12 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 251 738 SH | 11 września 2026 | Dziennie |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 155 SH | 30 września 2026 | Dziennie |
| TOK · iShares Trust | 0,01% | 564 SH | 11 września 2026 | Dziennie |
| URTH · iShares, Inc. | 0,01% | 18 452 SH | 11 września 2026 | Dziennie |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 9 234 SH | 1 października 2026 | Dziennie |
| ACWI · iShares Trust | 0,01% | 65 230 SH | 11 września 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 173 475 SH | 19 sierpnia 2026 | Dziennie |
| FTLS · First Trust Exchange-Traded Fund III | -0,15% | -50 276 NS | 31 lipca 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 14 lipca 2026 | Dziennie |
| ISCB · iShares Trust | · | 8 790 SH | 11 września 2026 | Dziennie |
| ISCV · iShares Trust | · | 25 681 SH | 11 września 2026 | Dziennie |
COO Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 23 analityków
KUP
Średni cel
$65.50
+15,1%
6 26,1%
Mocne kupno
7 30,4%
Kup
10 43,5%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
14 analityków · 2026-09-27Średnia cel $66.21 +16,3%
← Poniżej wszystkich celów
Aktualna cena $56.91
Niski$58.00
Średnia$66.21
Wysoki$75.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| MDLN | · | -4200.0 | 11.5% | 4.1% | 21.6% | 26.4% |
| SOLV | $13.75B | 8.9 | 0.86% | 18.7% | 35.8% | 53.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
BLUECHIP_DIP
Zrealizowano stop loss
ryzyko 1
nagroda 1,92
wejście
$68.92
R:R 1,92
BLUECHIP_DIP
Zrealizowano stop loss
ryzyko 1
nagroda 1,85
wejście
$70.55
R:R 1,85
Obecnie brak otwartego sygnału — żadna karta nie jest wypełniona, i to jest uczciwe.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Wrz 9, 2026